http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105709233-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0052
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
filingDate 2016-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105709233-B
titleOfInvention A kind of magnetic targeting nanodiamond drug and its preparation method and application
abstract The present invention provides a magnetic targeting nanodiamond medicine and a preparation method and application thereof. The carboxylated magnetic Fe 3 O 4 and nanodiamonds (ND) were formed into a magnetic nanodiamond composite (Fe 3 O 4 ‑PLL‑ND) under the action of the coupling agent polylysine (PLL); Anticancer drug doxorubicin (DOX), obtained magnetic targeting nanodiamond drug (Fe 3 O 4 ‑PLL‑ND‑DOX); under the action of an external magnetic field, the magnetic targeting drug was combined with human cervical cancer (HeLa) cells It can target and inhibit tumor growth. Using tumor-bearing mice as a model to study its magnetic targeting effect in vivo, it shows that it can target and localize to tumor sites. The magnetic targeting nanodiamond drug can be used in the preparation of magnetic targeting antitumor drugs.
priorityDate 2016-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103705944-B
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9TKU7
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535365
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP17153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ20EU8
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451197127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11747
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53782903
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ4R4H7
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416344866
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1KVQ9
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID308
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ06SH2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159859309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6093274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104903
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281626
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48036
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP14668
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70075
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID337132
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08758
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25673
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451261245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453753194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24380
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5R1W0

Total number of triples: 52.